路易斯安那州在FDA审查中要求法院暂停审理时, 限制mifepristone面临延误。 Louisiana's bid to restrict mifepristone faces delay as Trump administration seeks court pause amid FDA review.

Trump政府要求联邦法院暂时停止路易斯安那州要求限制获得堕胎药丸Mifepristone的诉讼, The Trump administration has asked a federal court to temporarily halt a Louisiana lawsuit seeking to restrict access to the abortion pill mifepristone, citing an ongoing internal review of the drug’s safety and regulatory status. 路易斯安那州认为,FDA的批发和邮购分发药丸是不安全的,并试图恢复亲自开处方的要求。 Louisiana argues the FDA’s approval and mail-order distribution of the pill are unsafe and seeks to reinstate in-person prescription requirements. 司法部认为,法院应当以程序理由驳回暂停请求,指出审查仍然很早。 The Justice Department contends the court should reject the pause request on procedural grounds, noting the review is still early. 2月24日的听讯定于2月24日举行,案件仍有待审理。 A hearing is set for February 24, and the case remains pending.